96760 ⎘
Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
Sub-classes:Compositions and Method of Use for Hair Straightening and Shaping
#2ANG (1-7) DERIVATIVE OLIGOPEPTIDES AND METHODS FOR USING AND PRODUCING THE SAME
#3Compositions and method of use for hair straightening and shaping
#4COMPOUNDS FOR REGULATING TRAINED IMMUNITY, AND THEIR METHODS OF USE
#5ULTRASHORT TETRAMERIC PEPTIDE NANOGELS SUPPORT TISSUE GRAFT FORMATION, WOUND HEALING AND 3D BIOPRINTING
#6Preparation of ceramide conjugates and derivatives of sphingolipid analogues
#7ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN
#8Compounds for regulating trained immunity, and their methods of use
#9Modified peptide nucleic acid compositions
#10Glycopeptides Increasing Lipid Synthesis
#11Compositions and method of use for hair straightening and shaping
#12TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS
#13Ang (1-7) derivative oligopeptides and methods for using and producing the same
#14ANALGESICS AND METHODS OF USE THEREOF
#15Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#16Conjugates of a glycoprotein or a glycan with a toxic payload
#17Preparation of ceramide conjugates and derivatives of sphingolipid analogues
#18ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN
#19Engineered O-glycosylation in recombinant polypeptides and uses thereof
#20Ang (1-7) derivative oligopeptides and methods for using and producing the same
#21Prevention of tissue ischemia and related methods
#22Ang (1-7) derivative oligopeptides for the treatment of pain
#23ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS
#24Site-selective modification of polysaccharides and applications thereof
#25Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications
#26Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#27Methods and compositions for the treatment of arthritis
#28Glycoprotein-toxic payload conjugates
#29Ang (1-7) derivative oligopeptides and methods for using and producing the same
#30Sugar-dipeptide conjugates
#31Polysaccharide derivative having membrane-permeable peptide chain
#32D-amino acid derivative-modified peptidoglycan and methods of use thereof
#33Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
#34Method for preparing multiple antigen glycopeptide carbohydrate conjugates
#35Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#36Functional lipid constructs
#37Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same
#38Site-selective modification of polysaccharides and applications thereof
#39D-amino acid derivative-modified peptidoglycan and methods of use thereof
#40Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
#41ANG-(1-7) derivative oligopeptides and methods for using and producing the same
#42Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#43METHOD FOR PURIFYING OLIGOSACCHARIDE PEPTIDE
#44Site-selective functionalization of glycopeptide antibiotics
#45Ang-(1-7) derivative oligopeptides and methods for using and producing the same
#46TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS
#47Disulfide masked prodrug compositions and methods
#48LINKER-PAYLOAD MOLECULE CONJUGATES
#49PSEUDOURIDIMYCIN (PUM) AND ITS DERIVATIVES
#50COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
#51Stabilized Peptide Helices For Inhibiting Dimerization Of Chemokine C Motif Receptor 2 (CCR2)
#52Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
#53Delta-Opioid Receptor Selective Analgesics
#54RNA targeting compounds and methods for making and using same
#55Kisspeptide-pentasaccharide conjugates
#56D-amino acid derivative-modified peptidoglycan and methods of use thereof
#57Multiligand constructs
#58PHARAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS
#59Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications
#60Angiopoietin derived peptides
#61SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION
#62Broad spectrum antibiotic arylomycin analogs
#63INHIBITION OF NONSENSE MEDIATED DECAY PATHWAYS
#64Derivatives of glyco-CF-serine and glyco-CF-threonine
#65Aziridine mediated native chemical ligation
#66Prevention of tissue ischemia and related compositions
#67Prevention of tissue ischemia and related methods
#68Delta-opioid receptor selective analgesics
#69Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
#70POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES
#71PURIFICATION OF PEPTIDE CONJUGATES BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY
#72Multiligand constructs
#73Glycopeptide constructs and uses thereof
#74Angiopoietin derived peptides
#75Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
#76Bioactive pentapeptides from rice bran and use thereof
#77Method of preparing glycopeptides
#78Glycopeptides and methods of making and using them
#79Collagen-binding synthetic peptidoglycans, preparation, and methods of use
#80Branched water-soluble polymers and their conjugates
#81USES OF IMMUNOLOGICALLY MODIFIED SCAFFOLD FOR TISSUE PREVASCULARIZATION CELL TRANSPLANTATION
#82Prevention of tissue ischemia, related methods and compositions
#83METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS
#84PHARMACEUTICALLY ACTIVE COMPOUNDS
#85Synthesis of glycopeptides with superior pharmacokinetic properties
#86Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
#87Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
#88O-linked glycosylation of peptides
#89Glycated peptides and methods of use
#90Method of separating a peptidoglycan recognition protein from a hemolymph larvae
#91GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES
#92GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES
#93Glycosylation of peptides via O-linked glycosylation sequences
#94GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES
#95O-LINKED GLYCOSYLATION OF PEPTIDES
#96GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES
#97Amphipathic glycopeptides
#98Pharmaceutical Preparation For the Oral Cavity
#99Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
#100ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#101Glycopeptides and Temperature-Responsive Micelles
#102MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE, VACCINE COMPRISING THE SAME AND USE THEREOF
#103HIV-1 glycopeptides and derivatives; preparation and applications thereof
#104Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
#105Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
#106PRODRUG COMPOSITION
#107Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
#108Branched water-soluble polymers and their conjugates
#109N-glycoside type glycolipids and hollow fiber type organic nanotubes made of the same
#110Prostate-specific antigen probes for optical imaging
#111Synthetic glyco-lipo-peptides as vaccines
#112Synthetic peptides, conjugation reagents and methods
#113Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
#114O-linked glycosylation of peptides
#115Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
#116Contulakin-G, analogs thereof and uses therefor
#117RP-HPLC method for the analysis and quantification of pancreatin active pharmaceutical agents
#118Methods for forming peptides and peptide conjugates and peptides and peptide conjugates compositions formed thereby